2008•American Journal of Clinical NutritionOpen access

Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects

Jerry R. Greenfield, I. Sadaf Farooqi, Julia M. Keogh, Elana Henning, Abdella M. Habib, Anthea Blackwood, Frank Reimann, Jens J. Holst, Fiona M. Gribble

Open full text 254 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 254 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Internal medicine, Endocrinology, Glutamine, Incretin, Insulin, Glucagon, Glucagon-like peptide-1, Gastric inhibitory polypeptide

Back to paper search Browse research topics Original source

Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects — Research Paper | ScholarLens